Evidence map›Paper›PMID 41280683›Full record

ArticleiScience2025

Multi-cellular phenotypic dynamics during the progression of an immunocompetent breast cancer model.

Louise Gsell, Spencer S Watson, Iva Sutevski, Matteo Massara, Klara Soukup, Alper Eroglu, Jeff E Mold, Antony Cougnoux, Johanna A Joyce, Jean Hausser

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Louise GsellDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden.
Spencer S WatsonLudwig Institute for Cancer Research, 1011 Lausanne, Switzerland.
Iva SutevskiDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden.
Matteo MassaraLudwig Institute for Cancer Research, 1011 Lausanne, Switzerland.
Klara SoukupLudwig Institute for Cancer Research, 1011 Lausanne, Switzerland.
Alper ErogluDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden.
Jeff E MoldDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden.
Antony CougnouxDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden.
Johanna A JoyceLudwig Institute for Cancer Research, 1011 Lausanne, Switzerland.
Jean HausserDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 65 Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The breast tumor microenvironment (TME) has recently been profiled at high resolution by performing single-cell RNA sequencing (scRNAseq) on patient samples. However, from patients' samples, analyzing the temporal dynamics of the TME is ethically, practically and scientifically challenging. Revealing these dynamics could structure inter-tumor heterogeneity into a temporally ordered sequence of causes and consequences in cellular events. Here, we survey the dynamics of the TME by performing scRNAseq at different time points of the progression of a mouse breast tumor allograft model driven by the PyMT antigen. We find that multi-cellular phenotypic dynamics follow one of three possible temporal patterns: stable colonization, wave-like, or progressive increase. In particular, IFN-responsive cancer cells,

Indexed as

cancerimmunologytranscriptomics

Identifiers

PMID41280683
PMCPMC12637086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.